Caspase-8 is required for cell death induced by expanded polyglutamine repeats

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Death Research

Background:

• Expanded polyglutamine repeats are implicated in neurodegenerative diseases like Huntington's disease (HD).
• The precise molecular mechanisms driving neuronal death in HD are not fully understood.
• Caspase-8 is a key mediator of apoptosis, but its role in HD pathogenesis requires clarification.

Purpose of the Study:

• To investigate the role of caspase-8 in neuronal cell death induced by expanded polyglutamine repeats.
• To determine if caspase-8 activation is involved in the pathological processes of Huntington's disease.

Main Methods:

• Primary rat neurons were transfected with expanded polyglutamine repeat constructs (Q79).
• Caspase-8 activity and recruitment were assessed using Western blot and co-immunoprecipitation.
• Cell viability was measured following inhibition of caspase-8 or co-expression with various inhibitors (CrmA, FADD DN, Bcl-2, Bcl-xL).
• Western blot analysis was performed on brain tissue from HD patients and controls.

Main Results:

• Expression of Q79 led to the recruitment and activation of caspase-8 in primary neurons.
• Inhibition of caspase-8 significantly blocked Q79-induced neuronal death.
• Co-expression of Q79 with caspase inhibitors (CrmA, FADD DN, Bcl-2, Bcl-xL) prevented caspase-8 recruitment and cell death.
• Activated caspase-8 was detected in the insoluble fraction of brain tissue from HD patients, but not controls.

Conclusions:

• Caspase-8 plays an essential role in polyglutamine-induced neuronal death.
• The findings suggest that caspase-8 activation and relocation are involved in the pathogenesis of Huntington's disease.
• Targeting caspase-8 may offer a therapeutic strategy for HD-related neurodegenerative diseases.